Status:
RECRUITING
Prolactin Release Through Breast Stimulation in Non-lactating Women - Who Does Respond?
Lead Sponsor:
University Hospital Tuebingen
Conditions:
Prolactin
Breast Stimulation
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Prolactin is a multifunctional hormone which acts in different cell types rather than just modulating reproduction and lactation. One additional point is its action on glucose metabolism which is desc...
Eligibility Criteria
Inclusion
- Women, aged between 18 and 45 years
- premenopausal (women, who had menses at any time in the preceding 24 consecutive months)
- BMI \< 25 kg/m²
- Ability to understand and voluntarily sign an informed consent document prior to any study related procedures
Exclusion
- Type 1 or Type 2 diabetes
- Intake of medication which may affect prolactin levels (e.g. Metoclopramide, Methyldopa, opiates, cimetidine), except birth control pill/hormonal contraception known hyperprolactinemia or hyperthyroidism
- any other serious illness that might impact the results as judged by the investigator (e.g. malignant disease, coronary heart disease)
- Pregnant / breastfeeding women (weaning at least 6 month ago)
- plastic breast surgery (with detachment of milk ducts)
- allergy to BPA-free plastic
Key Trial Info
Start Date :
February 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05208684
Start Date
February 21 2022
End Date
December 1 2024
Last Update
May 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Tuebingen, Otfried-Mueller Str. 10
Tübingen, Germany, 72076